Access to Essential Medicines and Diagnostic Tests for Cardiovascular Diseases in Maputo City, Mozambique
References
- Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390(10100): 1151–210. DOI: 10.1016/S0140-6736(17)32152-9
- Bowry ADK, Lewey J, Dugani SB, Choudhry NK. The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management. Canadian Journal of Cardiology. 2015; 31(9): 1151–9. DOI: 10.1016/j.cjca.2015.06.028
- UNITED NATIONS (UN). Department of Economic and Social Affairs. Sustainable Development. Goals 3. Ensure healthy lives and promote well-being for all at all ages.
https://sdgs.un.org/goals/goal3 (accessed July 2022). - World Health Organization (WHO). Global Action Plan for the Prevention and Control of NCDs 2013–2020.
https://www.who.int/nmh/events/ncd_action_plan/en/ (accessed July 2022). - Sliwa K.
World Heart Federation . Speaking with one voice ‘25 by 25’- Is that achievable for Africa. African Summit; Khartoum, Sudan.https://www.world-heart-federation.org/wp-content/uploads/2017/10/WHF-African-Summit-Day-1-25x25-KSliwa.pdf (accessed July 2022). - World Health Organization (WHO).
WHO medicines strategy . Geneva: World Health Organization.http://apps.who.int/medicinedocs/documents/s16336e/s16336e.pdf (accessed July 2022). - World Health Organization (WHO). Medium-term strategic plan 2008–2013.
https://apps.who.int/gb/e/e_amtsp2.html (accessed July 2022). - Yuyun MF, Sliwa K, Kengne AP, Mocumbi AO, Bukhman G. Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective. Glob Heart. 2020; 15(1): 15. DOI: 10.5334/gh.403
- Silva-Matos C, Beran D. Non-communicable diseases in Mozambique: risk factors, burden, response and outcomes to date. Globalization and Health. 2012; 8: 37. DOI: 10.1186/1744-8603-8-37
- United Nations Development Programme (UNDP) Mozambique. Empowering Mozambicans to a resilient future.
https://www.undp.org/mozambique (accessed July 2021). - Dávila J, Kyrou E, Nunez T, Sumich J.
Urbanisation and Municipal Development in Mozambique: Urban Poverty and Rural-Urban Linkages . University College London; 2008.https://docplayer.net/21661345-Urbanisation-and-municipal-development-in-mozambique-urban-poverty-and-rural-urban-linkages.html (accessed July 2022). - Paulo M, Rosario C, Tvedten I.
Social Relations of Urban Poverty in Maputo, Mozambique . CMI – Chr Michelsen Institute; 2007. - The World Bank. The World Bank in Mozambique. Overview.
https://www.worldbank.org/en/country/mozambique/overview (accessed July 2022). - Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases. PLOS ONE. 2017; 12(2):
e0171284 . DOI: 10.1371/journal.pone.0171284 - World Health Organization (WHO) and Health Action International (HAI).
Measuring medicine prices, availability, affordability and price components . 2nd edition. World health Organization.https://apps.who.int/iris/handle/10665/70013 (accessed July 2022). - Instituto Nacional de Estatística (INE). Recenciamento Geral da População e Habitação (RGPH 2017).
http://www.ine.gov.mz/operacoes-estatisticas/censos/censo-2007/censo-2017 ; (accessed July 2022). - World Health Organization (WHO). Priority life-saving medicines for women and children 2012.
https://www.who.int/reproductivehealth/publications/general/emp_mar2012.1/en/ ; (accessed July 2022). - Management Sciences for Health I. International Medical Products Price Guide.
https://www.msh.org/resources/international-medical-products-price-guide (accessed July 2022). - Sharma A, Kaplan WA, Satheesh G, Poudyal IP, Gyawali P, Neupane D, et al. Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal. Glob Heart. 2021; 16(1): 38. DOI: 10.5334/gh.927
- Mocumbi AO, Sliwa K. Women’s cardiovascular health in Africa. Heart (British Cardiac Society). 2012; 98(6): 450–5. DOI: 10.1136/heartjnl-2011-301025
- Bukhman G, Mocumbi AO, Atun R, Becker AE, Bhutta Z, Binagwaho A, et al. The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion. Lancet (London, England). 2020; 396(10256): 991–1044. DOI: 10.1016/S0140-6736(20)31907-3
- Russo G, McPake B. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings. Health Policy and Planning. 2010; 25(1): 70–84. DOI: 10.1093/heapol/czp042
- Wagenaar BH, Gimbel S, Hoek R, Pfeiffer J, Michel C, Manuel JL, et al. Stock-outs of essential health products in Mozambique – longitudinal analyses from 2011 to 2013. Tropical Medicine and International Health: TM & IH. 2014; 19(7): 791–801. DOI: 10.1111/tmi.12314
- Instituto Nacional de Estatística (INE). Relatório Final do Inquérito ao Orçamento Familiar – IOF2014/15. 2016.
http://www.ine.gov.mz/operacoes-estatisticas/inqueritos/inquerito-sobre-orcamento-familiar (accessed July 2022). - Satheesh G, Sharma A, Puthean S, Ansil TP M, E J, Raj Mishra S, et al. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India. Tropical Medicine and International Health. 2020; 25(12): 1467–79. DOI: 10.1111/tmi.13494
- Colgan S, Faasse K, Martin LR, Stephens MH, Grey A, Petrie KJ. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open. 2015; 5(12):
e008915 . DOI: 10.1136/bmjopen-2015-008915 - Jingi AM, Noubiap JJ, Ewane Onana A, Nansseu JR, Wang B, Kingue S, et al. Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, availability and affordability in the West Region of Cameroon. PLoS One. 2014; 9(11):
e111812 . DOI: 10.1371/journal.pone.0111812 - Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organization. 2011 Jun 1; 89(6): 412–21. DOI: 10.2471/BLT.10.084327
- Steinbrook R. Closing the Affordability Gap for Drugs in Low-Income Countries. The New England Journal of Medicine. 2007; 357: 1996–9. DOI: 10.1056/NEJMp0706918
- Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet (London, England). 2009; 373(9659): 240–9. DOI: 10.1016/S0140-6736(08)61762-6
- Alpern JD, Stauffer WM, Kesselheim AS. High-Cost Generic Drugs — Implications for Patients and Policymakers. New England Journal of Medicine. 2014; 371(20): 1859–62. DOI: 10.1056/NEJMp1408376
- Sharma A, Rorden L, Ewen M, Laing R. Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology. Journal of Pharmaceutical Policy and Practice. 2016; 9(1): 12. DOI: 10.1186/s40545-016-0059-5
DOI: https://doi.org/10.5334/gh.1186 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jul 31, 2022
Accepted on: Jan 23, 2023
Published on: Feb 28, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Neusa Jessen, Abhishek Sharma, Jennifer Jones, Tangeni Auala, Sainimere Boladuadua, Ahmadou Jingi, Jose Ferrer, Ana Olga Mocumbi, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.